Abstract

Serotonin (5-HT) is widely implicated as a key neurotransmitter relevant to a range of psychiatric disorders and psychological processes. The role of central nervous 5-HT function underlying these processes can be examined through serotonergic challenge methodologies. Acute tryptophan depletion (ATD) is a key challenge method whereby a diminished dietary intake of tryptophan—the amino acid precursor to brain 5-HT synthesis—results in temporary diminished central nervous 5-HT synthesis. While this particular methodology has been used in adult populations, it was only recently that modifications were made to enable the use of ATD in child and adolescent populations. Additionally, the Moja-De modification of the ATD challenge methodology has demonstrated benefits over other ATD techniques used previously. The aim of this protocol paper is to describe the ATD Moja-De methodology in detail, its benefits, as well as studies that have been conducted to validate the procedure in child and adolescent samples. The ATD Moja-De protocol provides a potential methodology for investigating the role of central nervous 5-HT via manipulation of brain tryptophan availability in human psychopathology from a developmental viewpoint.

Highlights

  • Serotonin (5-HT) is a neurotransmitter that is involved in a variety of psychiatric disorders, such as depressive disorders, anxiety disorders, and attention deficit hyperactivity disorder (ADHD)

  • This study explored the effects of Acute tryptophan depletion (ATD) and the reduction of brain 5-HT synthesis on behavioral inhibition in passive avoidance learning assessed in a computerized go/no-go task

  • This study investigated the effects of diminished central nervous system 5-HT synthesis on plasma concentrations of relevant AAs using the ATD Moja-De protocol

Read more

Summary

INTRODUCTION

Serotonin (5-HT) is a neurotransmitter that is involved in a variety of psychiatric disorders, such as depressive disorders, anxiety disorders, and attention deficit hyperactivity disorder (ADHD). Biskup & colleagues [23] validated a refined body weight adapted ATD protocol called Moja-De in two strains of mice, while Sanchez & colleagues [24] examined the neurochemical effects of three developed formulas (ATD MojaDe for 5-HT, phenylalanine/tyrosine depletion or PTD for dopamine (DA) and a combined monoamine depletion mixture or CMD) on brain 5-HT and DA function in mice Both studies concluded that the Moja-De protocol lowered brain TRP and significantly decreased central nervous 5-HT synthesis. The body-weight-adjusted ATD protocol has been proven to successfully lead to TRP depletion and a decreased CNS of 5-HT, which has enabled Moja-De to be a valid tool to explore the central nervous serotonergic system and related aspects of TRP synthesis. Every use in human populations needs to be carefully evaluated (risk vs. benefits analysis) before the beverages are used

Summary
DISCUSSION
Findings
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call